Stockscreener 앱 받기
2.54
4.15%
-0.11
시장 영업 전:
2.54
전일 마감가:
$2.65
열려 있는:
$2.64
하루 거래량:
14.69M
Relative Volume:
1.05
시가총액:
$919.11M
수익:
$241.53M
순이익/손실:
$-389.92M
주가수익비율:
-2.065
EPS:
-1.23
순현금흐름:
$-323.54M
1주 성능:
+40.33%
1개월 성능:
+20.95%
6개월 성능:
+31.61%
1년 성능:
-73.79%
1일 변동 폭
$2.47
$2.72
1주일 범위
$2.08
$2.74
52주 변동 폭
$1.6385
$9.9267
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
명칭
Iovance Biotherapeutics Inc
전화
(650) 260-7120
주소
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.54 | 940.81M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-05-12 | 다운그레이드 | Truist | Buy → Hold |
| 2025-05-09 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-07-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-09-18 | 재확인 | Barclays | Overweight |
| 2023-05-30 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 재개 | Wells Fargo | Equal Weight |
| 2023-01-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-31 | 개시 | Guggenheim | Neutral |
| 2022-08-18 | 재개 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Stifel | Hold → Buy |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2021-06-10 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-05-03 | 개시 | Truist | Buy |
| 2021-04-16 | 개시 | Goldman | Buy |
| 2021-03-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-02-26 | 재확인 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-10-01 | 개시 | Stifel | Buy |
| 2019-04-29 | 개시 | Piper Jaffray | Overweight |
| 2019-02-28 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-07 | 개시 | Robert W. Baird | Outperform |
| 2018-12-31 | 재개 | B. Riley FBR | Buy |
| 2018-07-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-04-10 | 업그레이드 | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 재확인 | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-01 | 재확인 | B. Riley FBR, Inc. | Buy |
모두보기
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Why Iovance Biotherapeutics Inc. (2LB) stock attracts wealthy investorsCPI Data & Proven Capital Preservation Methods - newser.com
Why Iovance Biotherapeutics Inc. (2LB) stock is listed among top recommendationsWeekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
How Iovance Biotherapeutics Inc. (2LB) stock moves in volatile trading sessionsTrade Entry Report & Weekly Setup with ROI Potential - newser.com
Why Iovance Biotherapeutics Inc. (2LB) stock benefits from AI revolutionWeekly Investment Summary & Free High Accuracy Swing Entry Alerts - newser.com
How Iovance Biotherapeutics Inc. (2LB) stock compares with market leadersMarket Growth Summary & Precise Swing Trade Alerts - newser.com
Quantitative breakdown of Iovance Biotherapeutics Inc. recent moveRate Hike & Daily Growth Stock Investment Tips - newser.com
Why Iovance Biotherapeutics Inc. stock attracts global investorsShare Buyback & Safe Entry Point Alerts - newser.com
Is Iovance Biotherapeutics Inc. (2LB) stock overpriced at current multiples2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-12 03:11:46 - newser.com
Will Iovance Biotherapeutics Inc. (2LB) stock beat growth indexesEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
Is Iovance Biotherapeutics Inc. stock poised for growthGold Moves & Growth Focused Stock Pick Reports - newser.com
Published on: 2025-11-11 13:09:35 - newser.com
Iovance Biotherapeutics: Base-Case Q3 Report Keeps 'Show Me' Mode - Seeking Alpha
Iovance Biotherapeutics Rides Positive Trial Results Amidst Mixed Market Signals - timothysykes.com
Why Iovance Biotherapeutics Inc. stock is favored by top institutionsEarnings Trend Report & Safe Capital Growth Trade Ideas - newser.com
Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around? - Yahoo Finance
Strategies to average down on Iovance Biotherapeutics Inc.Weekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Is it time to cut losses on Iovance Biotherapeutics Inc.Wall Street Watch & Low Risk Growth Stock Ideas - newser.com
How Iovance Biotherapeutics Inc. stock trades during market volatilityJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Using fundamentals and technicals on Iovance Biotherapeutics Inc.Portfolio Risk Summary & Daily Entry Point Alerts - newser.com
What earnings margins imply for Iovance Biotherapeutics Inc. (2LB) stockNew Guidance & Smart Allocation Stock Reports - newser.com
Does Iovance Biotherapeutics Inc. stock trade at a discount to peersPortfolio Return Summary & Real-Time Volume Analysis Alerts - newser.com
Iovance Biotherapeutics (BIT:1IOVA) Price Target Decreased by 13.64% to 7.25 - Nasdaq
Will Iovance Biotherapeutics Inc. stock gain from lower inflation2025 Year in Review & Fast Gain Swing Trade Alerts - newser.com
Published on: 2025-11-09 03:03:36 - newser.com
Analysts Have Made A Financial Statement On Iovance Biotherapeutics, Inc.'s (NASDAQ:IOVA) Third-Quarter Report - 富途牛牛
Here's What Analysts Are Forecasting For Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) After Its Third-Quarter Results - simplywall.st
IOVA Soars 28% on Narrower-Than-Expected Loss in Q3, Revenues Up Y/Y - Nasdaq
Iovance Stock Faces Pressure Amid Legal Probes and Revised Revenue Guidance - StocksToTrade
Iovance Biotherapeutics Faces Shareholder Investigation Amid Financial Concerns - timothysykes.com
Is Iovance Biotherapeutics (IOVA) Undervalued? A Fresh Look at Valuation After Recent Share Price Rebound - Yahoo Finance
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2025 Earnings Call Transcript - Insider Monkey
Chardan Cuts Price Target on Iovance Biotherapeutics to $17 From $20, Keeps Buy Rating - MarketScreener
Iovance Biotherapeutics Inc (IOVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
자본화:
|
볼륨(24시간):